Arrowhead Pharmaceuticals, Inc. (ARWR)
76.43
-2.71
(-3.42%)
USD |
NASDAQ |
May 07, 12:02
Arrowhead Pharmaceuticals SG&A Expense (TTM) : 143.05M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 491.72M |
| Johnson & Johnson | 24.60B |
| Biogen, Inc. | 2.468B |
| Merck & Co., Inc. | 10.88B |
| Vertex Pharmaceuticals, Inc. | 1.357B |